Skip to main content
SpringerLink
Log in

Proteomics Toward Biomarkers Discovery and Risk Assessment

  • Chapter
  • First Online:
Interdisciplinary Concepts in Cardiovascular Health

  • 490 Accesses

Abstract

Cardiovascular diseases are among the leading causes of morbidity and mortality in Western societies and developing countries. The ability to investigate the complete proteome provides a critical tool toward elucidating the complex and multifactorial basis of cardiovascular biology, especially disease processes such as myocardial infarction, heart failure, stroke, and peripheral arterial disease. Different strategies have been used to discover novel potential biomarkers related to cardiovascular risk. It seems evident that a combination of biomarkers from different pathological pathways adds substantial prognostic information with respect to the risk of death from cardiovascular causes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alvarez-Llamas G, de la Cuesta F, Barderas ME, Darde V, Padial LR, Vivanco F (2008) Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics 5(5):679–691

    Article  PubMed  CAS  Google Scholar 

  • Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 11:845–867

    Google Scholar 

  • Anderson NL, Anderson NG (2003) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2(1):50

    Article  CAS  Google Scholar 

  • Anderson PA, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK (1995) Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 76(4):681–686

    Article  PubMed  CAS  Google Scholar 

  • Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers (2012) Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 58(1):54–61

    Article  PubMed  CAS  Google Scholar 

  • Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, Van Eyk J, Ouzounian M, MacLennan D, Emili A, Liu P (2006) Cardiovascular genomic medicine. Tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 48:1733–1741

    Article  PubMed  CAS  Google Scholar 

  • Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW, CAPTURE Investigators (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440–1445

    Article  PubMed  CAS  Google Scholar 

  • Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss G, Sharrett AR (2004) Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 109:837–842

    Article  PubMed  CAS  Google Scholar 

  • Barderas MG, Laborde CM, Posada M, de la Cuesta F, Zubiri I, Vivanco F, Alvarez-Llamas G (2011) Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases. J Biomed Biotechnol 2011:790132

    Article  PubMed  Google Scholar 

  • Batsis JA, Lopez-Jimenez F (2010) Cardiovascular risk assessment-From individual risk prediction to estimation of global risk and change in risk in the population. BMC Med 8:29–34

    Article  PubMed  Google Scholar 

  • Beer LA, Tang H, Barnhart KT, Speicher DW (2011) Plasma biomarker discovery using 3D protein profiling coupled with label-free quantitation. Methods Mol Biol 728:3–27

    Article  PubMed  CAS  Google Scholar 

  • Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95

    Article  Google Scholar 

  • Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, STARD Group (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 49:1–6

    Article  PubMed  CAS  Google Scholar 

  • Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595–1604

    Article  PubMed  CAS  Google Scholar 

  • Cook NR (2007) Used and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928–935

    Article  PubMed  Google Scholar 

  • Cook NR (2008) Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 54:17–26

    Article  PubMed  CAS  Google Scholar 

  • Cooke JP, Wilson AM (2010) Biomarkers of peripheral arterial disease. J Am Coll Cardiol 55:2017–2023

    Article  PubMed  CAS  Google Scholar 

  • Cortese DA (2007) A vision of individualized medicine in the context of global health. Clin Pharmacol Ther 82:491–493

    Article  PubMed  CAS  Google Scholar 

  • Cubedo J, Padró T, García-Moll X, Pintó X, Cinca J, Badimon L (2011) Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction. J Proteome Res 10(1):211–220

    Article  PubMed  CAS  Google Scholar 

  • Daniels LB (2011) Combining multiple biomarkers for cardiovascular risk assessment: more is usually better-up to a point. Bioanalysis 3(15):1679–1682

    Article  PubMed  CAS  Google Scholar 

  • de la Cuesta F, Alvarez-Llamas G, Maroto AS, Donado A, Zubiri I, Posada M, Padial LR, Pinto AG, Barderas MG, Vivanco F (2011) A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics 10(4):M110.003517

    Article  PubMed  Google Scholar 

  • de la Cuesta F, Barderas MG, Calvo E, Zubiri I, Maroto AS, Darde VM, Martin-Rojas T, Gil-Dones F, Posada-Ayala M, Tejerina T, Lopez JA, Vivanco F, Alvarez-Llamas G (2012) Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J Proteomics 75(10):2960–2971

    Article  PubMed  Google Scholar 

  • Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120:2177–2187

    Article  PubMed  Google Scholar 

  • Edwards AVG, White MY, Cordwell SJ (2008) The role of proteomics in clinical cardiovascular biomarker discovery. Mol Cell Proteomics 7:1824–1837

    Article  PubMed  CAS  Google Scholar 

  • Finley Austin MJ, Babiss L (2006) Commentary: where and how could biomarkers be used in 2016. AAPS J 8(1):E185–E189

    Article  PubMed  CAS  Google Scholar 

  • Gerszten RE, Carr SA, Sabatine M (2010) Integration of proteomic-based tools for improved biomarkers of myocardial injury. Clin Chem 56(2):194–201

    Article  PubMed  CAS  Google Scholar 

  • Gerszten RE, Asnani A, Carr SA (2011) Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. Circ Res 109:463–474

    Article  PubMed  CAS  Google Scholar 

  • Gilstrap LG, Wang TJ (2012) Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem 58(1):72–82

    Article  PubMed  CAS  Google Scholar 

  • Haas B, Serchi T, Wagner DR, Gilson G, Planchon S, Renaut J, Hoffmann L, Bohn T, Devaux Y (2011) Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker. J Proteomics 75(1):229–236

    Article  PubMed  CAS  Google Scholar 

  • Halim SA, Newby LK, Ohman EM (2012) Biomarkers in cardiovascular clinical trials: past, present, future. Clin Chem 58(1):45–53

    Article  PubMed  CAS  Google Scholar 

  • Hatoum IJ, Cook NR, Nelson JJ, Rexrode KM, Rimm EB (2011) Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women. Am Heart J 161:516–522

    Article  PubMed  CAS  Google Scholar 

  • Hawkridge AM, Heublein DM, Bergen HR 3rd, Cataliotti A, Burnett JC Jr, Muddiman DC (2005) Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 102(48):17442–17447

    Article  PubMed  CAS  Google Scholar 

  • Heidrich FM, Zhang K, Estrada M, Huang Y, Giordano FJ, Ehrlich BE (2008) Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes. Circ Res 102(10):1230–1238

    Article  PubMed  CAS  Google Scholar 

  • Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ (2010) Carotid plaque formation and serum biomarkers. Atherosclerosis 213:21–29

    Article  PubMed  CAS  Google Scholar 

  • Hunkeler NM, Kullman J, Murphy AM (1991) Troponin I isoform expression in human heart. Circ Res 69(5):1409–1414

    Article  PubMed  CAS  Google Scholar 

  • Kettman JR, Coleclough C, Frey JR, Lefkovits I (2002) Clonal proteomics: one gene – family of proteins. Proteomics 2(6):624–631

    Article  PubMed  CAS  Google Scholar 

  • Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ (1992) Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116(1–2):155–162

    Article  PubMed  CAS  Google Scholar 

  • Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT, Sabatine MS, Gerszten RE, Carr SA (2009) Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin Chem 55(6):1108–1117

    Article  PubMed  CAS  Google Scholar 

  • Kullo IJ, Cooper LT (2010) Early identification of cardiovascular risk using genomics and proteomics. Nat Rev Cardiol 7(6):309–317

    Article  PubMed  CAS  Google Scholar 

  • Lange V, Picotti P, Domon B, Aebersold R (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222

    Article  PubMed  Google Scholar 

  • Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321–328

    Article  PubMed  CAS  Google Scholar 

  • Libby P, Ridker PM (2004) Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116(Suppl 6A):9S–16S

    Article  PubMed  Google Scholar 

  • Manolio T (2003) Novel risk markers and clinical practice. N Engl J Med 349(17):1587–1589

    Article  PubMed  CAS  Google Scholar 

  • Marko-Varga G, Fehniger TE (2004) Proteomics and disease: the challenge for technology discovery. J Proteome Res 3:167–178

    Article  PubMed  CAS  Google Scholar 

  • McDonnell LA, Heeren RMA (2007) Imaging mass spectrometry. Mass Spectrom Rev 26:606–643

    Article  PubMed  CAS  Google Scholar 

  • Melanson SE, Tanasijevic MJ, Jarolim P (2007) Cardiac troponin assays: a view from the clinical chemistry laboratory. Circulation 116(18):e501–e504

    Article  PubMed  Google Scholar 

  • Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM (2007) Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 50:159–165

    Article  PubMed  CAS  Google Scholar 

  • Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra J, Dominiczak AF (2009) Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev 28(5):703–724

    Article  PubMed  CAS  Google Scholar 

  • Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC (2007) Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49:1993–2000

    Article  PubMed  CAS  Google Scholar 

  • Molins B, Peña E, de la Torre R, Badimon L (2011) Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow. Cardiovasc Res 92(2):328–337

    Article  PubMed  CAS  Google Scholar 

  • Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, Hazen SL (2008) Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 29:1096–1102

    Article  PubMed  CAS  Google Scholar 

  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25):3143–3421

    Google Scholar 

  • Packard CJ, O’Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343:1148–1155

    Article  PubMed  CAS  Google Scholar 

  • Patterson SD (2003) Data analysis – the Achilles heel of proteomics. Nat Biotechnol 21:221–222

    Article  PubMed  CAS  Google Scholar 

  • Pencima NJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker. From area under the ROC curve to reclassification and beyond. Stat Med 27:157–172

    Article  Google Scholar 

  • Petricoin EF, Liotta LA (2004) Proteomic approaches in cancer risk and response assessment. Trends Mol Med 10:59–63

    Article  PubMed  CAS  Google Scholar 

  • Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, Bassetti S, Steuer S, Winkler K, Peter F, Meissner J, Haaf P, Potocki M, Drexler B, Osswald S, Mueller C (2011) Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124(2):136–145

    Article  PubMed  CAS  Google Scholar 

  • Rhee EP, Gerszten RE (2012) Metabolomics and cardiovascular biomarker discovery. Clin Chem 58(1):139–147

    Article  PubMed  CAS  Google Scholar 

  • Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347(20):1557–1565

    Article  PubMed  CAS  Google Scholar 

  • Roger LV, Jacobsen SJ, Weston SA, Goraya TY, Kilian J, Reeder GS, Kottke TE, Yawn BP, Frye RL (2002) Trends in incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979–1994. Ann Intern Med 136:341–348

    Article  PubMed  Google Scholar 

  • Røsjø H, Husberg C, Dahl MB, Stridsberg M, Sjaastad I, Finsen AV, Carlson CR, Oie E, Omland T, Christensen G (2010) Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium. Circ Heart Fail 3(4):503–511

    Article  PubMed  Google Scholar 

  • Schmidt AM, Yan SD, Wautier JL, Stern D (1999) Activation of receptor for advance glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489–497

    Article  PubMed  CAS  Google Scholar 

  • Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D’Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ (2009) Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373(9665):739–745

    Article  PubMed  Google Scholar 

  • Sturgeon C, Hill R, Hortin GL, Thompson D (2010) Taking a new biomarker into routine use – a perspective from the routine clinical biochemistry laboratory. Proteomics Clin Appl 4:892–903

    Article  PubMed  CAS  Google Scholar 

  • Thakur SS, Geiger T, Chatterjee B, Bandilla P, Fröhlich F, Cox J, Mann M (2011) Deep and highly sensitive proteome coverage by LC-MS/MS without prefractionation. Mol Cell Proteomics 10(8):M110.003699

    Article  PubMed  Google Scholar 

  • Van Eyk JE (2011) The maturing of proteomics in cardiovascular research. Circ Res 108:490–498

    Article  PubMed  Google Scholar 

  • van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF, Martinez A, Crijns HJ, MacRae CA, Menheere PP, Pinto YM (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48(6):1217–1224

    Article  PubMed  Google Scholar 

  • Vasan RS (2006) Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113:2335–2362

    Article  PubMed  Google Scholar 

  • Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS (2005) Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 4:409–418

    Article  PubMed  CAS  Google Scholar 

  • Vivanco F, Darde V, De la Cuesta F, Barderas MG (2006) Cardiovascular proteomics. Curr Proteomics 3:147–170

    Article  CAS  Google Scholar 

  • Vivanco F, De la Cuesta F, Barderas MG, Zubiri I, Alvarez-Lamas G (2011) Cardiovascular proteomics. In: Garcia A, Senis YA (eds) Platelet proteomics. Principles, analysis and applications. Wiley, Hoboken

    Google Scholar 

  • Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS (2008) Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 51(19):1874–1882

    Article  PubMed  CAS  Google Scholar 

  • Wang TJ (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355:2631–2639

    Article  PubMed  CAS  Google Scholar 

  • Wang TJ (2011) Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 123:551–565

    Article  PubMed  Google Scholar 

  • Wang J, Balu N, Canton G, Yuan C (2010) Imaging biomarkers of cardiovascular disease. J Magn Reson Imaging 32(3):502–515

    Article  PubMed  Google Scholar 

  • Watson CJ, Ledwidge MT, Phelan D, Collier P, Byrne JC, Dunn MJ, McDonald KM, Baugh JA (2011) Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure. Circ Heart Fail 4(2):188–197

    Article  PubMed  CAS  Google Scholar 

  • Wilson PW (2011) Prediction of cardiovascular disease events. Cardiol Clin 29:1–13

    Article  PubMed  Google Scholar 

  • Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18):1837–1847

    Article  PubMed  CAS  Google Scholar 

  • Zethelius B, Berglund L, Sunström J, Ingelsson E, Basu S, Larson A, Venge P, Ärnlöv J (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358:2107–2116

    Article  PubMed  CAS  Google Scholar 

  • Zhang J, Guy MJ, Norman HS, Chen YC, Xu Q, Dong X, Guner H, Wang S, Kohmoto T, Young KH, Moss RL, Ge Y (2011) Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J Proteome Res 10(9):4054–4065

    Article  PubMed  CAS  Google Scholar 

  • Zimmermann-Ivol CG, Burkhard PR, Le Floch-Rohr J, Allard L, Hochstrasser DF, Sanchez JC (2004) Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol Cell Proteomics 3(1):66–72

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, IIS-Fundacion Jimenez Diaz, Madrid, Spain

    Gloria Alvarez-Llamas

  2. Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain

    Fernando de la Cuesta

  3. Department of Vascular Physiopathology, Laboratorio de Fisiopatología Vascular, Hospital Nacional de Parapléjicos, SESCAM, Edificio de Terapia 2ª planta, Toledo, 45071, Spain

    Maria G. Barderas

Authors
  1. Gloria Alvarez-Llamas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando de la Cuesta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria G. Barderas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria G. Barderas .

Editor information

Editors and Affiliations

  1. Department of Environmental and Preventi, Hyogo College of Medicine, Hyogo, Japan

    Ichiro Wakabayashi

  2. Institute of Biophysics, Medical University of Graz Center for Physiological Medicine, Graz, Austria

    Klaus Groschner

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Alvarez-Llamas, G., de la Cuesta, F., Barderas, M.G. (2013). Proteomics Toward Biomarkers Discovery and Risk Assessment. In: Wakabayashi, I., Groschner, K. (eds) Interdisciplinary Concepts in Cardiovascular Health. Springer, Cham. https://doi.org/10.1007/978-3-319-01050-2_5

Download citation

Publish with us

Policies and ethics

Search

Navigation